Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Data advance knowledge in breast cancer research
July 21st, 2005
Breast cancer data are the focus of recent research from the United States and South Korea. Study 1: Recent research from the United States published in the journal Breast Cancer Research and Treatment has elucidated the differential sensitivities of trastuzumab (Herceptin)-resistant human breast cancer cells to phosphoinositide-3 kinase (PI-3K) and epidermal growth factor receptor (EGFR) kinase inhibitors. "Her2 (erbB2/neu) is overexpressed in 25-30% of human breast cancers. Herceptin is a recombinant humanized Her2 antibody used to treat breast cancer patients with Her2 overexpression. "Over a 5-month selection process,...
Source: Women's Health Weekly (2005-07-21)
|
